Oct 30th Day 2

09:04

Controlling Infectious Diseases

09:04

Evaluating RSV vaccine candidates: What is missing?

09:04

Formulation and Analytical Approaches

09:04

Promising Immunotherapy Approaches

09:04

Targeted Vaccine Developments

09:04

Veterinary Vaccine Technologies

10:35

Morning Networking Break

Immuno-oncology
11:35

Insight on future combination strategies

- Are we effectively incorporating profiling techniques into R&D to better understand the underlying cellular mechanisms and “build” better combinations?
12:34

Manufacturing Platforms & Practices

13:04

Profiling & Response

13:35

Networking Lunch & Poster Session

15:04

Vector-borne and parasitic diseases

Emerging Diseases
15:05

Norovirus vaccines in development

Sean Tucker, Chief Scientific Officer And Vice President Research, Vaxart
15:34

Global Health Manufacture

16:05

Afternoon Networking Break

16:34

Big Data & Cancer Immunotherapy

17:04

Managing Bacterial Diseases

18:15

Chair closing remarks of day two followed by Drinks Reception host by Nexelis

last published: 04/Nov/19 16:05 GMT